Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the study of PROHIBITIN-TP01 in patients with metastatic prostate cancer and obesity is now displayed, including its study details and record history.
    Difference
    43%
    Check dated 2026-11-08T04:42:06.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The study record page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:51:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:51:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T01:39:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page update adds a Revision tag and removes multiple institution names, locations, and MeSH terms from the study metadata, altering how the study is presented and indexed on the page.
    Difference
    18%
    Check dated 2026-09-20T00:54:41.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.